Enabling allogeneic T cell-based therapies: Scalable stirred-tank bioreactor mediated manufacturing

Authors

Lisa Prendergast, Lonza, United Kingdom
Inbar Friedrich Ben-Nun, Cell and Gene Therapy Research and Development, Lonza Inc., Rockville, MD, USAFollow

Conference Dates

February 4 - 8, 2024

Abstract

Please click Additional Files below to see the full abstract.

Recommended Citation

Lisa Prendergast and Inbar Friedrich Ben-Nun, "Enabling allogeneic T cell-based therapies: Scalable stirred-tank bioreactor mediated manufacturing" in "Advancing Manufacture of Cell and Gene Therapies VIII", Fernanda Masri, Cytomos, United Kingdom; Carolyn Yeago, CY Solutions LLC, USA; Gargi Maheshwari, BMS, USA; John Moscariello, BMS, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/cell_gene_therapies_viii/49